Just a while back, I crossed paths with this incredible lady battling IgAN and advanced CKD. From being a top pediatrician to a patient advocate, she's killing it! Loma Linda U. Health ❤️

Shoutout to National Kidney Foundation Silvi Shah, MD, MS for having us on board. Brittany's journey is truly inspiring! 🌟

Become #APOL1Aware and join American Kidney Fund for AMKD Awareness Day on April 30. Learn more about APOL1’s connection to kidney disease and spread the word: kidneyfund.org/APOL1aware

Today marks a significant milestone as we come together to recognize the first National APOL1-Mediated Kidney Disease (AMKD) Awareness Day. AMKD is a genetic condition that affects individuals of western and central African heritage, leading to a higher risk of kidney disease. 
.

Join GlomCon in its Kidney Transplantation Series this Sunday:

Updates in Transplant Onconephrology by Dr. Naoka Murakami and Dr. Germaine Wong

ID: 875 5077 1266
Passcode 202122

sign up 👉🏻 bit.ly/signup-glomcon

#GlomCon

Histo-tools on NEPTUNE and CureGN Repositories for the Creation of Image-Based Biomarkers by Dr. Andrew Janowczyk

Total live participants: 101
From 36 countries

Watch the session here 👉🏻 my.glomcon.org

#GlomCon

Close to 40% of Asante speaking Ghanaians, Yoruba and Igbo speaking Nigerians have high risk APOL1 genotype. Let’s clear controversies and work on solving the problem ⁦KDIGO⁩ Opeyemi Olabisi Morgan Grams ⁦Kirk Campbell⁩ ⁦SSC_Lab 🧬⁩

Join GlomCon China in its inaugural conference:
10 a.m. Beijing time on May 5 (GMT+8)

Title: Exploration and evaluation of predictors of disease progression in Alport syndrome

Speaker: Lin Fujun, Department of Nephrology, Xinhua Hospital Affiliated to Shanghai Jiao Tong

Join GlomCon China in its inaugural conference:
10 a.m. Beijing time on May 5 (GMT+8)

Title: Exploration and evaluation of predictors of disease progression in Alport syndrome

Speaker: Lin Fujun, Department of Nephrology, Xinhua Hospital Affiliated to Shanghai Jiao Tong

参加 GlomCon China 的首届会议：
北京时间5 月 5 日上午 10 点（GMT+8）

题目: Alport 综合征疾病进展预测指标的探索与评价

讲者: 林芙君, 上海交通大学医学院附属新华医院肾脏科

主持人: 刘松, 助理教授, 新墨西哥大学附属医院

#腾讯会议 ：577-409-841
会议密码：123456

#GlomConChina

Starting now 👇

About to start! Vamos lá? GlomCon Portugal @GlomCon

¡Wohoo! 😎

Nos vemos en Hawaii en agosto 2024☀️🏖️

¡Regístrate!

GlomCon
GlomConILA

🚨European Commission Approves sparsentan for the treatment of IgA Nephropathy

“This is a significant step forward for patients [...] with IgAN, a rare and serious condition, and a leading cause of end-stage renal disease,” said Jürgen Floege, M.D.
👇

ir.travere.com/news-releases/…

🔬For renal pathologists, we currently have a reader study open on kidney transplant biopsies to validate #DeepLearning algorithms to improve transplant diagnostics. Please feel free to leave your details here: forms.gle/vi5Gz9AvpjJzSH…, rewarded with coauthorship on 2 papers 🤩

Review of FSGS Classification With a Focus on Genetic 🧬 Associations ca. 2024 from Kidney Medicine GlomCon Marco Bonilla Haresh Selvaskandan Nasim Wiegley, MD, FASN #Nephpearls

sciencedirect.com/science/articl…

Join GlomCon and Renal Pathology Society this Sunday:

Histo-tools on NEPTUNE and CureGN Repositories for the Creation of Image-Based Biomarkers by Dr. Andrew Janowczyk

ID: 875 5077 1266
Passcode 202122

sign up 👉🏻 bit.ly/signup-glomcon

#GlomCon

Kidney Biopsy in the Management of Lupus Nephritis: The Evidence and the Gaps by Dr. Juan M. Mejia-Vilet and Dr. Sonia Rodriguez-Ramirez

Total live participants: 237
From 58 countries

Watch the session here 👉🏻 my.glomcon.org

#GlomCon